Wannamaker, Paul
18  results:
Search for persons X
?
1

Safety, Tolerability, Pharmacokinetics, and Acceptability o..:

Han, Kelong ; Wannamaker, Paul ; Lu, Hongzhou...
Antimicrobial Agents and Chemotherapy.  66 (2022)  3 - p. , 2022
 
?
2

1037. Qualitative Findings from a Hybrid III Implementation..:

Czarnogorski, Maggie ; Garris, Cindy ; Wannamaker, Paul...
Open Forum Infectious Diseases.  7 (2020)  Supplement_1 - p. S549-S549 , 2020
 
?
3

1034. Patient Perspectives on Implementation of a Long-Acti..:

Garris, Cindy ; D'Amico, Ronald ; Wannamaker, Paul...
Open Forum Infectious Diseases.  7 (2020)  Supplement_1 - p. S547-S548 , 2020
 
?
 
?
 
?
6

Twice‐Daily Trizivir versus Combivir‐Abacavir in Antiretrov..:

For the ESS40005 Study Team ; Fischl, Margaret A. ; Burnside Jr., Alfred F....
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.  23 (2003)  11 - p. 1432-1440 , 2003
 
?
 
?
10

Segmentation of plate coupling, fate of subduction fluids, ..:

Wannamaker, Philip E. ; Evans, Rob L. ; Bedrosian, Paul A....
Geochemistry, Geophysics, Geosystems.  15 (2014)  11 - p. 4230-4253 , 2014
 
?
 
?
 
?
15

Leukotactic Activity and Reduction of Nitroblue Tetrazolium..:

Hill, Harry R. ; Kaplan, Edward L. ; Dajani, Adnan S...
The Journal of Infectious Diseases.  129 (1974)  3 - p. 322-326 , 1974
 
1-15